To elucidate the molecular mechanisms by which CTD-3252C9.4 inhibits IFI6 expression, we first studied the cellular localization of CTD-3252C9.4 in pancreatic cancer cells. This evidence concerns the gene IFI6 and pancreatic neoplasm.